In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés ...

Pharmacogenomics (PGx) is the study of how genetic variation affects the efficacy and safety of medicines, enabling ...

New OHE insight on immunisation: despite high returns on investment, global spending lags. We outline why and how countries ...

This is the first in a series of OHE Insights on the history, implications and possible impact of President Trump’s Executive Order on a “Most Favoured Nation” (MFN) pricing model for pharmaceuticals.